Jeffrey B. Mirviss - 03 Dec 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Periph Intervent
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 03 Dec 2022
Net transactions value: -$13,794
Form type: 4
Filing time: 05 Dec 2022, 15:20:41 UTC
Previous filing: 21 Apr 2022
Next filing: 12 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Gift	$0	-26	-0.02%	$0.000000	110,290	16 May 2022	Direct
transaction	BSX	Common Stock	Gift	$0	-230	-0.21%	$0.000000	110,639	01 Nov 2022	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$0	+649	+0.59%	$0.000000	111,288	03 Dec 2022	Direct	F2
transaction	BSX	Common Stock	Tax liability	$13,794	-296	-0.27%	$46.60	110,992	03 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-649	-50%	$0.000000	649	03 Dec 2022	Common Stock	649		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes shares acquired on June 30, 2022 under the Boston Scientific Employee Stock Purchase Plan (formerly Boston Scientific Global Employee Stock Purchase Plan) based upon the most current data available.
F2	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 3, 2019, the first anniversary of the date of grant.